Lubiprostone
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76420-907 -
Package NDC
76420-907-01 -
Package NDC
76420-907-30 -
Package NDC
76420-907-60 -
Package NDC
76420-907-90 -
Application number
NDA021908 -
SPL ID
2cbe759e-e896-7ada-e063-6394a90a6cc5 -
SPL set ID
f5653f3b-c3c8-487c-bc00-3770985aa5ee -
UNII
7662KG2R6K -
RxCUI
616578 -
RxCUI
794639
What the source publishes
- Labeler
- Asclemed USA, Inc.
- Active ingredients
- lubiprostone
- Form
- CAPSULE, GELATIN COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA AUTHORIZED GENERIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Lubiprostone",
"splId": "2cbe759e-e896-7ada-e063-6394a90a6cc5",
"labels": [
{
"setId": "f5653f3b-c3c8-487c-bc00-3770985aa5ee",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f5653f3b-c3c8-487c-bc00-3770985aa5ee",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f5653f3b-c3c8-487c-bc00-3770985aa5ee"
}
],
"routes": [
"ORAL"
],
"labeler": "Asclemed USA, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "100 CAPSULE, GELATIN COATED in 1 BOTTLE (76420-907-01)",
"package_ndc": "76420-907-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20250128"
},
{
"sample": false,
"description": "30 CAPSULE, GELATIN COATED in 1 BOTTLE (76420-907-30)",
"package_ndc": "76420-907-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20250128"
},
{
"sample": false,
"description": "60 CAPSULE, GELATIN COATED in 1 BOTTLE (76420-907-60)",
"package_ndc": "76420-907-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20250128"
},
{
"sample": false,
"description": "90 CAPSULE, GELATIN COATED in 1 BOTTLE (76420-907-90)",
"package_ndc": "76420-907-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20250128"
}
],
"productId": "76420-907_2cbe759e-e896-7ada-e063-6394a90a6cc5",
"useDomain": "unknown",
"dosageForm": "CAPSULE, GELATIN COATED",
"productNdc": "76420-907",
"deaSchedule": null,
"genericName": "lubiprostone",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LUBIPROSTONE",
"strength": "24 ug/1"
}
],
"applicationNumber": "NDA021908",
"marketingCategory": "NDA AUTHORIZED GENERIC",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230101",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175573",
"N0000175456"
],
"unii": [
"7662KG2R6K"
],
"rxcui": [
"616578",
"794639"
],
"spl_set_id": [
"f5653f3b-c3c8-487c-bc00-3770985aa5ee"
],
"pharm_class_epc": [
"Chloride Channel Activator [EPC]"
],
"pharm_class_moa": [
"Chloride Channel Activators [MoA]"
],
"manufacturer_name": [
"Asclemed USA, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76420-907_2cbe759e-e896-7ada-e063-6394a90a6cc5"